Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (271-280 of 357) with videos related to

Pageof 36
Sort By:
Molecular Medicine (Cambridge, Mass.)|August 4, 2007
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancerKathryn M Taylor, Helen E Morgan, Kathryn Smart, et al.
Clinical Oncology|June 1, 1984
The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot studyF C Campbell, D A Morgan, H M Bishop, et al.
Leukemia|October 1, 1993
Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study GroupM J Brisco, J Condon, E Hughes, et al.
British Journal of Cancer|December 19, 2001
E-cadherin as a prognostic indicator in primary breast cancerC Parker, R S Rampaul, S E Pinder, et al.
Breast Cancer Research : BCR|March 15, 2011
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1Iain R Hutcheson, Lindy Goddard, Denise Barrow, et al.
Cancer|December 15, 1980
Relationship between primary breast tumor receptor status and patient survivalR W Blamey, H M Bishop, J R Blake, et al.
Cancer Research|April 1, 1994
Transforming growth factor-alpha and endocrine sensitivity in breast cancerR I Nicholson, R A McClelland, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
International Journal of Cancer|August 22, 1995
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, I O Ellis, J F Robertson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapyR I Nicholson, R A McClelland, J M Gee, et al.
Pageof 36

Showing results (271-280 of 357) with videos related to

Sort By:
Pageof 36
Molecular Medicine (Cambridge, Mass.)|August 4, 2007
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancerKathryn M Taylor, Helen E Morgan, Kathryn Smart, et al.
Clinical Oncology|June 1, 1984
The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot studyF C Campbell, D A Morgan, H M Bishop, et al.
Leukemia|October 1, 1993
Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study GroupM J Brisco, J Condon, E Hughes, et al.
British Journal of Cancer|December 19, 2001
E-cadherin as a prognostic indicator in primary breast cancerC Parker, R S Rampaul, S E Pinder, et al.
Breast Cancer Research : BCR|March 15, 2011
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1Iain R Hutcheson, Lindy Goddard, Denise Barrow, et al.
Cancer|December 15, 1980
Relationship between primary breast tumor receptor status and patient survivalR W Blamey, H M Bishop, J R Blake, et al.
Cancer Research|April 1, 1994
Transforming growth factor-alpha and endocrine sensitivity in breast cancerR I Nicholson, R A McClelland, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
International Journal of Cancer|August 22, 1995
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, I O Ellis, J F Robertson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapyR I Nicholson, R A McClelland, J M Gee, et al.
Pageof 36